⌘K

Login Start Free

Home/Filings/4/0001181431-11-007229

4//SEC Filing

RAAB G KIRK 4

Accession 0001181431-11-007229

CIK 0001178711other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:58 PM ET

Size

5.6 KB

Accession

0001181431-11-007229

Insider Transaction Report

Form 4

Period: 2011-02-02

Transcept Pharmaceuticals IncTSPT

Director

Transactions

Award
Stock Option (right to buy)
2011-02-02+38,000→ 38,000 total
Exercise: $8.20Exp: 2021-02-02→ Common Stock (38,000 underlying)

Footnotes (1)

[F1]The option vests in forty-eight equal monthly installments beginning February 27, 2011.

Documents

1 file

4
rrd299700.xmlPrimary
2011 ANNUAL GRANT

Issuer

Transcept Pharmaceuticals Inc

CIK 0001178711

Entity typeother

Related Parties

1

filerCIK 0001210530

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 6:58 PM ET
Size: 5.6 KB

View on SEC.gov